Profile
| Metric | Value |
|---|---|
| Full Name | Pediatrix Medical Group, Inc. |
| Ticker | NYSE: MD |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | pediatrix.com |
| Employees | 4,120 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $22.24 | |
| Price, 1D Change | +1.41% | |
| Market Cap | $2B | |
| - | ||
| PE Ratio | 11.74 | |
| Beta | 0.77 | |
| Revenue | $2B | |
| Revenue, 1Y Change | +0.92% | |
| EPS | -$1.19 | |
| EPS, 1Y Change | -61.78% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | PDX | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$1.19 | |
| EPS Estimate | $2.08 | |
| EPS Est. Change | +275.36% | |
| Revenue | $2.01B | |
| Revenue Estimate | $1.91B | |
| Revenue Est. Change | -5.30% | |
| Current Price | $22.24 | |
| Price Target | - | $22.00 |
| Price Tgt. Change | - | -1.08% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.25 | -$0.73 | -158.79% | |
| $1.35 | -$1.19 | -188.13% | |
| $2.08 | N/A | +275.36% | |
| $2.19 | N/A | +283.93% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.02B | $1.99B | -1.33% | |
| $2.00B | $2.01B | +0.81% | |
| $1.91B | N/A | -5.30% | |
| $1.96B | N/A | -2.70% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +74.71% | |
| Price, 3Y | +48.56% | |
| Market Cap, 1Y | +74.73% | |
| Market Cap, 3Y | +53.81% | |
| Revenue, 1Y | +0.92% | |
| Revenue, 3Y | +5.32% | |
| EPS, 1Y | -61.78% | |
| EPS, 3Y | -177.91% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $22.24 | |
| SMA 200 | $16.52 | |
| SMA 200 vs Price | -25.73% | |
| SMA 50 | $22.02 | |
| SMA 50 vs Price | -1.01% | |
| Beta | 0.77 | |
| ATR | $0.66 | |
| 14-Day RSI | 53.49 | |
| 10-Day Volatility | 24.34% | |
| 1-Year Volatility | 51.04% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $2.01B | |
| EPS | -$1.19 | |
| Gross Profit | $422.12M | |
| Gross Margin | 20.97% | |
| Operating Profit | $183.68M | |
| Operating Margin | 9.13% | |
| Net Income | -$99.07M | |
| Net Margin | -4.92% | |
| EBITDA | -$28.37M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.80 | |
| Current Ratio | 1.47 | |
| Quick Ratio | 1.47 | |
| - | ||
| F-Score | 8 | |
| Altman Z-Score | 1.62 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 11.74 | |
| PS Ratio | 0.99 | |
| PB Ratio | 2.14 | |
| EV/EBITDA | 8.11 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $764.94M | |
| Cash & Equivalents | $229.94M | |
| Total Assets | $2.15B | |
| Current Assets | $639.61M | |
| Total Liabilities | $1.39B | |
| Current Liabilities | $434.11M | |
| Total Debt | $662.31M | |
| Short Term Debt | $33.25M | |
| Accounts Payable | $46.43M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $1.83B | |
| Operating Expenses | $270.66M | |
| Cost Of Goods Sold | $1.59B | |
| SG&A | $238.44M | |
| D&A | $32.23M | |
| Interest Expense | $0.00 | |
| Income Tax | -$2.27M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $206.57M | |
| CFI | -$35.41M | |
| CFF | -$14.49M | |
| Capex | $22.02M | |
| Free Cash Flow | $184.55M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Truist Securities | → | |
| UBS | → | |
| Leerink Partners | → | |
| UBS | → | |
| UBS | → | |
| Macquarie | → | |
| Truist Securities | → | |
| UBS | → | |
| Truist Securities | → | |
| Truist Securities | → |
Analyst sentiment
Institutional ownership
Screeners with MD
Data Sources & References
- MD Official Website www.pediatrix.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/893949/000119312525261640/0001193125-25-261640-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/893949/000095017025023730/0000950170-25-023730-index.htm
- MD Profile on Yahoo Finance finance.yahoo.com/quote/MD
- MD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/md
FAQ
What is the ticker symbol for Pediatrix Medical Group, Inc.?
The ticker symbol for Pediatrix Medical Group, Inc. is NYSE:MD
Does Pediatrix Medical Group, Inc. pay dividends?
No, Pediatrix Medical Group, Inc. does not pay dividends
What sector is Pediatrix Medical Group, Inc. in?
Pediatrix Medical Group, Inc. is in the Healthcare sector
What industry is Pediatrix Medical Group, Inc. in?
Pediatrix Medical Group, Inc. is in the Medical Care Facilities industry
What country is Pediatrix Medical Group, Inc. based in?
Pediatrix Medical Group, Inc. is headquartered in United States
When did Pediatrix Medical Group, Inc. go public?
Pediatrix Medical Group, Inc. initial public offering (IPO) was on September 20, 1995
Is Pediatrix Medical Group, Inc. in the S&P 500?
No, Pediatrix Medical Group, Inc. is not included in the S&P 500 index
Is Pediatrix Medical Group, Inc. in the NASDAQ 100?
No, Pediatrix Medical Group, Inc. is not included in the NASDAQ 100 index
Is Pediatrix Medical Group, Inc. in the Dow Jones?
No, Pediatrix Medical Group, Inc. is not included in the Dow Jones index
When was Pediatrix Medical Group, Inc. last earnings report?
Pediatrix Medical Group, Inc.'s most recent earnings report was on November 3, 2025
When does Pediatrix Medical Group, Inc. report earnings?
The next expected earnings date for Pediatrix Medical Group, Inc. is February 19, 2026
